Cargando…
Evaluation of Two Adjuvant Formulations for an Inactivated Yellow Fever 17DD Vaccine Candidate in Mice
The attenuated yellow fever (YF) vaccine is one of the most successful vaccines ever developed. After a single dose administration YF vaccine can induce balanced Th1/Th2 immune responses and long-lasting neutralizing antibodies. These attributes endorsed it as a model of how to properly stimulate th...
Autores principales: | Cajaraville, Ana Carolina dos Reis Albuquerque, Gomes, Mariana Pierre de Barros, Azamor, Tamiris, Pereira, Renata Carvalho, Neves, Patrícia Cristina da Costa, De Luca, Paula Mello, de Lima, Sheila Maria Barbosa, Gaspar, Luciane Pinto, Caride, Elena, Freire, Marcos da Silva, Medeiros, Marco Alberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9865672/ https://www.ncbi.nlm.nih.gov/pubmed/36679918 http://dx.doi.org/10.3390/vaccines11010073 |
Ejemplares similares
-
Duration of Humoral and Cellular Immunity 8 Years After Administration of Reduced Doses of the 17DD-Yellow Fever Vaccine
por: da Costa-Rocha, Ismael Artur, et al.
Publicado: (2019) -
Subdoses of 17DD yellow fever vaccine elicit equivalent virological/immunological kinetics timeline
por: Campi-Azevedo, Ana Carolina, et al.
Publicado: (2014) -
Corrigendum: Duration of Humoral and Cellular Immunity 8 Years After Administration of Reduced Doses of the 17DD-Yellow Fever Vaccine
por: da Costa-Rocha, Ismael Artur, et al.
Publicado: (2019) -
Description of a Prospective 17DD Yellow Fever Vaccine Cohort in Recife, Brazil
por: de Melo, Andréa Barbosa, et al.
Publicado: (2011) -
Impact of synthetic and biological immunomodulatory therapy on the duration of 17DD yellow fever vaccine-induced immunity in rheumatoid arthritis
por: Ferreira, Clarissa de Castro, et al.
Publicado: (2019)